Immunodiagnostic Systems Holdings plc (“IDS” or “the Company” or “the Group”), a leading solution provider to the clinical laboratory diagnostic market, is pleased to announce that Klaus Peter Kaspar, aged 63, will join the Board of IDS as a NonExecutive Director with effect from 1 November 2015. Peter has over 35 years’ of experience in life sciences and diagnostics. From 2005 […]